Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?
- PMID: 24150108
- DOI: 10.3233/JAD-131394
Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?
Abstract
Data found in literature have reported that bacterial endotoxins may be involved in the inflammatory and pathological processes associated with amyloidosis and Alzheimer's disease (AD). In fact, it has been observed that the chronic infusion of the bacterial lipopolysaccharide, the outer cell wall component of Gram negative bacteria, into the fourth ventricle of rats reproduces many of the inflammatory and pathological features seen in the brain of AD patients. In this context, a key player in the pathogenesis of AD is the amyloid-β peptide (Aβ) that is capable of aggregating in fibrils that represent the main component of amyloid plaques. These deposits that accumulate among brain cells are indeed one of the hallmarks of AD. This aggregation in fibrils seems to correlate with Aβ toxic effects. However, recent data have shown that amyloid fibril formation not only results in toxic aggregates but also provides biologically functional molecules; such amyloids have been identified on the surface of fungi and bacteria. The aim of this work was to gain insight into the influence of bacterial endotoxins on Aβ fibrillogenesis; factors that influence fibril formation may be important for Aβ toxic potential. Following three days of incubation at 37°C, Aβ was organized in compact fibrils and the in vitro Aβ fibrillogenesis was potentiated by the Escherichia coli endotoxin. This suggests the importance of infectious events in the pathogenesis of AD and proposes a new aspect related to the putative pathological factors that can be implicated in the mechanisms involved in Aβ25-35 fibrillogenesis.
Keywords: Alzheimer's disease; Escherichia coli; amyloid-β; lipopolysaccharide; transmission electron microscopy.
Similar articles
-
S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.J Pept Sci. 2013 Mar;19(3):159-65. doi: 10.1002/psc.2484. Epub 2013 Jan 24. J Pept Sci. 2013. Retraction in: J Pept Sci. 2016 Jun;22(6):434. doi: 10.1002/psc.2889. PMID: 23349038 Retracted.
-
Curcuminoid binds to amyloid-β1-42 oligomer and fibril.J Alzheimers Dis. 2011;24 Suppl 2:33-42. doi: 10.3233/JAD-2011-102100. J Alzheimers Dis. 2011. PMID: 21335654
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide.FEBS J. 2011 Feb;278(4):634-42. doi: 10.1111/j.1742-4658.2010.07984.x. Epub 2011 Jan 17. FEBS J. 2011. PMID: 21205198
-
In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.Subcell Biochem. 2012;65:53-74. doi: 10.1007/978-94-007-5416-4_3. Subcell Biochem. 2012. PMID: 23224999 Review.
Cited by
-
GSK3β Substrate-competitive Inhibitors Regulate the gut Homeostasis and Barrier Function to Inhibit Neuroinflammation in Scopolamine-induced Alzheimer's Disease Model Mice.Inflammation. 2024 Aug 24. doi: 10.1007/s10753-024-02133-z. Online ahead of print. Inflammation. 2024. PMID: 39180577
-
Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer's Disease (AD).J Alzheimers Dis Parkinsonism. 2015 Mar;5(1):177. doi: 10.4172/2161-0460.1000177. J Alzheimers Dis Parkinsonism. 2015. PMID: 25977840 Free PMC article.
-
The Role of the Neural Exposome as a Novel Strategy to Identify and Mitigate Health Inequities in Alzheimer's Disease and Related Dementias.Mol Neurobiol. 2025 Jan;62(1):1205-1224. doi: 10.1007/s12035-024-04339-6. Epub 2024 Jul 5. Mol Neurobiol. 2025. PMID: 38967905 Free PMC article. Review.
-
The gastrointestinal tract microbiome and potential link to Alzheimer's disease.Front Neurol. 2014 Apr 4;5:43. doi: 10.3389/fneur.2014.00043. eCollection 2014. Front Neurol. 2014. PMID: 24772103 Free PMC article. Review. No abstract available.
-
Neuroinflammation in neurodegeneration via microbial infections.Front Immunol. 2022 Jul 28;13:907804. doi: 10.3389/fimmu.2022.907804. eCollection 2022. Front Immunol. 2022. PMID: 36052093 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources